Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) closed at $3.62 in the last session, down -1.23% from day before closing price of $3.67. In other words, the price has decreased by -$1.23 from its previous closing price. On the day, 0.52 million shares were traded. AMLX stock price reached its highest trading level at $3.83 during the session, while it also had its lowest trading level at $3.54.
Ratios:
We take a closer look at AMLX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 6.67 and its Current Ratio is at 6.67. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on November 18, 2024, Upgraded its rating to Outperform and sets its target price to $11 from $3 previously.
On October 23, 2024, BofA Securities Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $4.20 to $10.
Mizuho Downgraded its Buy to Neutral on March 18, 2024, whereas the target price for the stock was revised from $32 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 03 ’25 when Klee Justin B. sold 4,595 shares for $3.15 per share. The transaction valued at 14,483 led to the insider holds 3,196,648 shares of the business.
Cohen Joshua B sold 4,595 shares of AMLX for $14,549 on Mar 03 ’25. The Co-Chief Executive Officer now owns 3,196,652 shares after completing the transaction at $3.17 per share. On Mar 03 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 1,611 shares for $3.12 each. As a result, the insider received 5,022 and left with 133,310 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 321184064 and an Enterprise Value of 146663952. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.68 while its Price-to-Book (P/B) ratio in mrq is 1.51. Its current Enterprise Value per Revenue stands at 1.679 whereas that against EBITDA is -0.504.
Stock Price History:
The Beta on a monthly basis for AMLX is -0.56, which has changed by 0.26748252 over the last 52 weeks, in comparison to a change of 0.09506309 over the same period for the S&P500. Over the past 52 weeks, AMLX has reached a high of $7.27, while it has fallen to a 52-week low of $1.58. The 50-Day Moving Average of the stock is 2.73%, while the 200-Day Moving Average is calculated to be 10.23%.
Shares Statistics:
According to the various share statistics, AMLX traded on average about 854.82K shares per day over the past 3-months and 1070990 shares per day over the past 10 days. A total of 68.63M shares are outstanding, with a floating share count of 63.80M. Insiders hold about 28.00% of the company’s shares, while institutions hold 56.46% stake in the company. Shares short for AMLX as of 1740700800 were 3652423 with a Short Ratio of 4.27, compared to 1738281600 on 2591408. Therefore, it implies a Short% of Shares Outstanding of 3652423 and a Short% of Float of 4.4299997.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
